In February 2020 the FDA saw the tests for Leronlimab from several hospitals of mild and seriously ill corona virus patients.
These human tests for covid 19, were only for that one disease, corona virus.
After examination of those hospital provided tests, the FDA was satisfied with the efficiency and safety of Leronlimab medication and promptly announced, that by mid July 2020 CYDY would be approved.
Mind you, this was only an approval for one disease, "Covid-19".
What ever negotiations with the FDA and agreement with Pourhassan at a later date must have confused every one, since they re-tested and added double cubic centimeters to Leronlimab and also tested for HIV.
How did that all happen???